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Why did Smith & Nephew invest in the SmartState™ 
Program?
Reali: No other state had a program that could match the 
benefits available through the SmartState Program. 
What we found in South Carolina provided a unique opportunity 
for collaboration among our company, a renowned university 
dedicated to research, and the ORFC, with a network of as-
sociated orthopedic clinics. This collaboration draws on the 
expertise of world-class academic, clinical, and commercial 
partners to research and develop new technologies that will 
help future generations of patients.
Advanced, biologic therapies are a new field for Smith & Nephew 
and one that requires strong partnerships to maximize the op-
portunities for success. We believe the SmartState collabora-
tion will help us meet our goals. The fact that South Carolina 
matched our investment dollar-for-dollar was also a powerful 
incentive.
How do you believe your company will benefit from 
this investment?
Reali: We are confident that our company will benefit in multiple 
ways. We believe that innovative new therapies can be initiated 
by public health and biomedical engineering research partners 
at USC, developed and advanced with the support of Smith & 
Nephew, and then studied carefully by the ORFC and its as-
sociated clinics. With the help of our partners, we will be able 
to evaluate the performance of new products and treatment 
approaches and to assess the potential they hold for helping 
patients to regain their lives. 
The SmartState Program also provides a cost-effective way 
to expand the breadth and depth of our research. We want to 
develop the right technologies in a way that adds value and is 
beneficial to patients and clinicians.
RESEARCH   •   INNOVATION   •   INVESTMENT
In 2009, global medical technology company 
Smith & Nephew announced that it would invest 
$5 million in a new partnership with the University 
of South Carolina (USC). The investment funds the 
Center of Economic Excellence in Rehabilitation and Reconstruction Sciences. 
The center brings together USC researchers, the Orthopedic Research 
Foundation of the Carolinas (ORFC), and the Biologics & Spine division of 
Smith & Nephew to research and develop cutting-edge orthopedic therapies 
and technologies. 
Why would one of the leading global orthopedics companies invest in South 
Carolina research? According to company leaders, investing in the SmartState Program gives 
Smith & Nephew a unique opportunity to investigate new technologies and therapies that can 
improve people’s lives. 
Below, Ken Reali, senior vice president and general manager of Smith & Nephew Biologics & 
Spine, shares more about his company’s interest in the SmartState Program.
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What do you see as the potential long-term advan-
tages of investing in the SmartState Program?
Reali: We anticipate benefits in working with world-class academic 
and clinical leaders through this program. Long-term, we hope 
to see innovative and cost-effective technologies developed for 
commercialization.
Our aim is to accomplish translational research, taking products 
from bench to bedside. In the Center of Economic Excellence in 
Rehabilitation and Reconstruction Sciences, we will be able to 
consult a broad range of clinicians as well as patients to better 
understand their needs and problems and to determine the right 
technology to help them meet those needs. 
The overarching theme of our involvement is helping people to 
improve their lives. We believe the work done in the new center will 
add value for our business, our customers, and their patients.
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The SmartState Program (formerly known as the Centers 
of Economic Excellence or CoEE Program) was created by 
the South Carolina legislature in 2002 and is funded through 
South Carolina Education Lottery proceeds. The legisla-
tion authorizes the state’s three public research institutions, 
Medical University of South Carolina, Clemson University and 
the University of South Carolina, to use state funds to create 
Centers of Economic Excellence in research areas that will 
advance South Carolina’s economy. Each Center is awarded 
from $2 million to $5 million in State Lottery funds, which must 
be matched on a dollar-for-dollar basis with non-state invest-
ment. To date, the SmartState Program has resulted in more 
than $400 million dollars in non-state investment in the South 
Carolina economy–more than a two-to-one return on the state’s 
investment. The SmartState Program is also responsible for 
the creation of more than 5,000 jobs. 
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For details on how your company can benefit by investing in the SmartState Program,  
please use the following contact information:
